NorthWest Biotherapeutics Inc (NWBO)

[staccani]

if phase 2 direct results are exceptional, ie killing tumor and creating immune memory, nwbo will seek approval and $3B market cap will look like peanuts. This is the kind of market cap that 3,000 patients pa would warrant, basically less than the annual solid tumor deaths in NY city only. Pyrr, while you seem to be quite conversant with the undelying science and statistics, you are way underestimating the financial magnitude of DCVax Direct if it will show similar effects with humans as with mice in pre clinical trials